Our results suggest that the systemic effect of α-OX40 and RT combined with overall effector CD8+ T cell priming and proliferation synergize to enhance local and systemic tumor control with the greatest impact achieved by triple combination therapy. This evidence concerns the gene CD8A and neoplasm.